Abstract
Accumulating evidence shows that deterioration of vascular endothelial function underlies the pathophysiology of cardiovascular diseases following lifestyle-related diseases. Both Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP), which are tripeptides derived from proteolytic hydrolysate of milk casein, inhibit angiotensin-converting enzyme (ACE), suggesting that both VPP and IPP may improve vascular endothelial function, because many ACE inhibitors are known to improve endothelial function. We investigated the effects of ACE-inhibitory food component in humans with mild hypertension, since there has been no report on such effects. The study was conducted by the placebo-controlled, double-blind crossover method in 25 male subjects with mild hypertension. After casein hydrolysate containing both VPP and IPP were administered for 1 week, reactive hyperemia of the left upper forearm was measured using plethysmography as an index of vascular endothelial function. Since one subject dropped out, we analyzed the data of 24 subjects. The reactive hyperemia of the left upper forearm was produced by a 5 min occlusion using inflation of a cuff. The maximum blood flow during reactive hyperemia was 20.8±6.7 mL/min/100 mL tissue in the placebo group, whereas it increased remarkably to 30.0±10.4 mL/min/100 mL tissue in the group administered casein hydrolysate containing both VPP and IPP (p<0.001). There was no change in systemic blood pressure, indicating that the improvement of the vascular endothelial function attributable to VPP and IPP is independent of hemodynamic changes. We conclude that casein hydrolysate containing VPP and IPP improves the vascular endothelial dysfunction in subjects with mild hypertension. The continuous intake of VPP and IPP could help to prevent cardiovascular diseases in hypertensive subjects.
Similar content being viewed by others
Article PDF
References
Lteif AA, Han K, Mather KJ : Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 2005; 112: 32–38.
Minamino T, Kitakaze M : Cellular mechanisms for the treatment of chronic heart failure: the nitric oxide- and adenosine-dependent pathways. Expert Opin Emerg Drugs 2002; 7: 99–110.
The SOLVD Investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302.
On YK, Kim CH, Oh BH, Lee MM, Park YB : Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 2002; 25: 365–371.
Hornig B, Kohler C, Drexler H : Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997; 95: 1115–1118.
Kajimoto O, Seki E, Osajima K, et al: Hypotensive effects of food containing peptide derived from sardine muscle hydrolyzate, in subjects with high-normal, or hypertension. J Nutr Food 2003; 6: 65–82.
Fujita H, Yasumoto R, Hasegawa M, Ohshima K : Human volunteers study on antihypertensive effect of “Katsuobushi oligo peptide” II: a placebo-controlled study on the effect of “Pepide soup” on blood pressure in borderline and hypertensive subjects. Jpn Pharmacol Ther 1997; 25: 2161–2165.
Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T : Purification and characterization of angiotensin I–converting enzyme inhibitors from sour milk. J Dairy Sci 1995; 78: 777–783.
Mizuno S, Nishimura S, Matsuura K, Gotou T, Yamamoto N : Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J Dairy Sci 2004; 87: 3083–3188.
Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T : A placebo-controlled study of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767–771.
Higashi Y, Sasaki S, Kurisu S, et al: Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects. Role of endothelium-derived nitric oxide. Circulation 1999; 100: 1194–1202.
Ross R : Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.
Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A : Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25: 455–460.
Perticone F, Ceravolo R, Pujia A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191–196.
Okura Y, Takao M, Zhang B, Nakashima Y, Saku K : Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res 2004; 27: 723–729.
Butler R, Morris AD, Struthers AD : Cigarette smoking in men and vascular responsiveness. Br J Clin Phamacol 2001; 52: 145–149.
Vigili de Kreutzenberg S, Kiwanuka E, Tiengo A, Avogaro A : Visceral obesity is characterized by impaired nitric oxide–independent vasodilatation. Eur Heart J 2003; 24: 1210–1215.
Taddei S, Virdis A, Mattei P, et al: Aging and endothelial function in normotensive subjects and patient with essential hypertension. Circulation 1995; 91: 1981–1987.
Taddei S, Virdis A, Ghiadoni L, et al: Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576–582.
Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA : Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510–2516.
Casino PR, Kilcoyne CM, Cannon RO 3rd, Quyyumi AA, Panza JA : Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol 1995; 75: 40–44.
O'Driscoll G, Green D, Taylor RR : Simvastatin: an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126–1131.
Sanada M, Higashi Y, Nakagawa K, et al: Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 2002; 87: 4634–4641.
Kitakaze M, Minamino T, Node K, et al: Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation 1995; 92: 950–961.
Gokce N, Holbrook M, Hunter LM, et al: Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol 2002; 40: 761–765.
Dahlof B, Pennert K, Hansson L : Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95–110.
Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D : Measuring forearm blood flow and interpreting the responses to drug and mediators. Hypertension 1995; 25: 918–923.
Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T : A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol 2001; 87: 121–125.
Higashi Y, Sasaki S, Nakagawa K, et al: A comparison of angiotenisn-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol 2000; 35: 284–291.
Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A : Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994; 90: 2285–2290.
Togashi N, Ura N, Higashimura K, Murakami H, Shimamoto K : The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000; 18: 1605–1610.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirota, T., Ohki, K., Kawagishi, R. et al. Casein Hydrolysate Containing the Antihypertensive Tripeptides Val-Pro-Pro and Ile-Pro-Pro Improves Vascular Endothelial Function Independent of Blood Pressure–Lowering Effects: Contribution of the Inhibitory Action of Angiotensin-Converting Enzyme. Hypertens Res 30, 489–496 (2007). https://doi.org/10.1291/hypres.30.489
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.489
Keywords
This article is cited by
-
Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB
Journal of Inflammation (2015)
-
Bioactive peptides of animal origin: a review
Journal of Food Science and Technology (2015)
-
Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes
International Journal of Diabetes in Developing Countries (2015)
-
The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats
Hypertension Research (2014)
-
Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial
Hypertension Research (2011)